Expert Adviser:

Leveraging her Ph.D. in cancer biology from Stanford University and years of experience in competitive intelligence, Stacey provides clients with unsurpassed coverage of Myeloproliferative Neoplasms (MPNs). Through the ONCrg Advisory services, you can contact Stacey directly for personalized answers to non-proprietary questions, targeted analyses, and custom insights in MPNs.   More

MPNs Oncology Resources

Medical Conference Coverage:

ONCrg Conference covers the entire MPNs landscape and delivers expert analysis of noteworthy scientific, clinical, and commercial changes at major medical conferences. Novel agents are emerging with promising efficacy and the treatment landscape is likely to evolve over the next 3-5 years.   More

Competitive Landscape Analysis:

With only one agent currently approved for MPNs (Incyte’s ruxolitinib), more therapies are needed. Novel approaches including targeted therapies and immunotherapies are showing promise. ONCrg quarterly reports deliver cutting edge profiles across the competitive landscape, providing valuable analytics by class and treatment subset for new drugs in Phase I/II development and beyond.   More

Monthly Surveillance Reports:

ONCrg Sentinel provides vigilant monitoring of rapidly evolving scientific, clinical, and commercial activities in oncology. ONCrg experts deliver incisive commentaries on current news events to inform subscribers each month, preparing them to respond wisely to ever-changing market conditions.   More